Green Thumb Industries Inc (GTBIF) is a publicly traded drug manufacturers - specialty and generic business based in the US which employs around 4,500 staff. Green Thumb Industries is listed on the OTCQX (a marketplace for buying and selling "over the counter" stocks which aren't listed on a formal stock exchange) and traded in US dollars. Its current price of $10.33 is 4.9% down on its price a month ago ($10.86).
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Green Thumb Industries), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.
Green Thumb Industries is a major part of the OTCQX, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).
Review technicals and fundamentals to help you determine if now's a good time for you to invest.
View Green Thumb Industries's price performance, share price volatility, historical data and technicals.
Historical closes compared with the last close of $10.33
| 1 week (2024-09-05) | 7.16% |
|---|---|
| 1 month (2024-08-14) | -4.88% |
| 3 months (2024-06-13) | -9.39% |
| 6 months (2024-03-14) | -19.80% |
| 1 year (2023-09-14) | -13.19% |
| 2 years (2022-09-14) | -7.52% |
| 3 years (2021-09-14) | -62.23% |
| 5 years (2019-09-12) | 8.51% |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Green Thumb Industries P/E ratio, PEG ratio and EBITDA.
Green Thumb Industries's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, Green Thumb Industries's shares trade at around 34x recent earnings.
Green Thumb Industries's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.3689. A PEG ratio below 1 can be interpreted as meaning the shares are not overvalued given the current rate of growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Green Thumb Industries's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Green Thumb Industries's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $338.3 million (£0.0 million).
The EBITDA is a measure of Green Thumb Industries's overall financial performance and is widely used to measure a its profitability.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Ever wondered how to buy shares in Canopy Growth? We explain how and compare a range of providers that can give you access to many brands, including Canopy Growth.
Ever wondered how to buy shares in Curaleaf Holdings? We explain how and compare a range of providers that can give you access to many brands, including Curaleaf Holdings.
Ever wondered how to buy shares in Genesis Healthcare? We explain how and compare a range of providers that can give you access to many brands, including Genesis Healthcare.
Ever wondered how to buy shares in Allergy Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Allergy Therapeutics.
Ever wondered how to buy shares in 4D pharma? We explain how and compare a range of providers that can give you access to many brands, including 4D pharma.
Ever wondered how to buy shares in Aurora Cannabis? We explain how and compare a range of providers that can give you access to many brands, including Aurora Cannabis.
Thinking about buying shares in Evgen Pharma? We explain how to do it and compare a range of providers who will give you access to global markets.
Ever wondered how to buy shares in Intuitive Surgical? We explain how and compare a range of providers that can give you access to many brands, including Intuitive Surgical.
Ever wondered how to buy shares in Stryker? We explain how and compare a range of providers that can give you access to many brands, including Stryker.
Ready to compare platforms?